Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Atrial fibrillation–induced neurocognitive and vascular dysfunction is averted by mitochondrial oxidative stress reduction
Pavithran Guttipatti, Ruiping Ji, Najla Saadallah, Uma Mahesh R. Avula, Deniz Z. Sonmez, Albert Fang, Eric Li, Amar D. Desai, Samantha Parsons, Parmanand Dasrat, Christine Sison, Yanping Sun, Chris N. Goulbourne, Steven R. Reiken, Elaine Y. Wan
Pavithran Guttipatti, Ruiping Ji, Najla Saadallah, Uma Mahesh R. Avula, Deniz Z. Sonmez, Albert Fang, Eric Li, Amar D. Desai, Samantha Parsons, Parmanand Dasrat, Christine Sison, Yanping Sun, Chris N. Goulbourne, Steven R. Reiken, Elaine Y. Wan
View: Text | PDF
Research Article Cardiology Vascular biology

Atrial fibrillation–induced neurocognitive and vascular dysfunction is averted by mitochondrial oxidative stress reduction

  • Text
  • PDF
Abstract

Atrial fibrillation (AF) is a prevalent arrhythmia with known detriments such as heart failure, stroke, and cognitive decline even in patients without prior stroke. The mechanisms by which AF leads to cognitive dysfunction are yet unknown, and there is a lack of animal models to study this disease process. We previously developed a murine model of spontaneous and prolonged episodes of AF, a double transgenic mouse model with cardiac-specific expression of a gain-of-function mutant voltage-gated sodium channel (DTG-AF mice). Herein, we show, for the first time to our knowledge, a murine model of AF without any cerebral infarcts exhibiting cognitive dysfunction, including impaired visual learning and cognitive flexibility on touch screen testing. Mesenteric resistance arterial function of DTG-AF mice showed significant loss of myogenic tone, increased wall thickness and distensibility, and mitochondrial dysfunction. Brain pial arteries also showed increased wall thickness and mitochondrial enlargement. Furthermore, DTG-AF mice have decreased brain perfusion on laser speckle contrast imaging compared with controls. Cumulatively, these findings demonstrate that AF leads to vascular structural and functional alterations necessary for dynamic cerebral autoregulation, resulting in increased cerebral stress and cognitive dysfunction. Expression of mitochondrial catalase (mCAT) to reduce mitochondrial reactive oxygen species (ROS) was sufficient to prevent vascular dysfunction due to AF, restore perfusion, and improve cognitive flexibility.

Authors

Pavithran Guttipatti, Ruiping Ji, Najla Saadallah, Uma Mahesh R. Avula, Deniz Z. Sonmez, Albert Fang, Eric Li, Amar D. Desai, Samantha Parsons, Parmanand Dasrat, Christine Sison, Yanping Sun, Chris N. Goulbourne, Steven R. Reiken, Elaine Y. Wan

×

Figure 6

Impaired visual learning and cognitive flexibility in DTG-AF mice rescuable by mCAT.

Options: View larger image (or click on image) Download as PowerPoint
Impaired visual learning and cognitive flexibility in DTG-AF mice rescua...
Data from Figure 1 visualized as dashed lines depicting the means of control and DTG-AF groups alongside mCAT-DTG-AF mice. Asterisks represent comparison between mCAT-DTG-AF and DTG-AF groups. (A) Expression of mCAT results in significantly improved performance in trials to criterion than DTG-AF with no difference from control. One-way ANOVA and Tukey’s test: DTG-AF versus mCAT-DTG-AF, P < 0.01; mCAT-DTG-AF versus control, P = NS) (n = 15 control, n = 24 DTG-AF, n = 17 mCAT-DTG-AF mice). (B) mCAT expression reduces the number of errors made by DTG-AF mice. (C) Percentage of mice reaching criterion at each day with mCAT-DTG-AF mice performing significantly better than DTG-AF mice (log-rank Mantel-Cox test, χ2 = 6.23, P = 0.01) and nonsignificantly different than control (χ2 = 0.43, P = 0.51) (*P < 0.02 per α corrected for multiple comparisons with Bonferroni’s). DTG-AF data from Figure 1 translucent. (D) mCAT expression improves days required to reach criterion compared with DTG-AF. (E) Correction trials to criterion demonstrate a similar pattern. (F) Percentage of mice reaching criterion each day after the correct stimulus is reversed. mCAT coexpression significantly improves number of mice reaching criterion each day compared with DTG-AF. Log-rank Mantel-Cox (DTG-AF versus mCAT-DTG-AF χ2 = 13.30, P <0.001) (mCAT-DTG-AF versus control χ2 = 2.18, P = 0.14) (n = 14 control, n = 19 DTG-AF, n = 15 mCAT-DTG-AF) (**P < 0.003 per α corrected for multiple comparisons with Bonferroni’s test). (G) mCAT coexpression significantly reduces days required to learn the reversed criterion. (H) Analysis of early reversal shows mCAT-DTG-AF mice unlearn the original criterion and reach 50% chance performance faster than DTG-AF and same as control mice. Data are shown as mean ± SEM, *P < 0.05, **P < 0.01, except as noted in F.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts